首页 正文

Evolution of Disease-modifying Therapy for Transthyretin Cardiac Amyloidosis

{{output}}
Transthyretin cardiac amyloidosis (ATTR-CA) represents an inexorably progressive and fatal cardiomyopathy. Increased understanding of the underlying pathogenesis responsible for the misfolding of transthyretin and the subsequent accumulation of amyloid fibrils... ...